Yahoo Finance

Checkpoint Therapeutics Reports First Quarter 2021 Financial Results and Recent Corporate Highlights

NEW YORK, May 06, 2021 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced financial results ...
Business Wire

CheckPoint Solutions Named Winner of the 2021 Calix Partner Innovation Award, Honored for Purpose-Built Solutions That Advance Broadband Provider Success

SAN JOSE, Calif.--(BUSINESS WIRE)--Calix, Inc. (NYSE: CALX) today announced that CheckPoint Solutions was named the winner of the 2021 Calix Partner Innovation award at Calix ConneXions 2021 in Las ...
ascopubs.org

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update

A multidisciplinary panel of medical oncology, dermatology, gastroenterology, rheumatology, pulmonology, endocrinology, neurology, hematology, emergency medicine ...
Business Wire

ImmunityBio to Present Preliminary Phase 2 Data of 68% Durable Disease Control with Anktiva Plus Checkpoint Inhibitor in First 140 Patients Enrolled with Lung Cancer and ...

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced an upcoming poster presentation highlighting its chemotherapy free ...
Nasdaq

Checkpoint Therapeutics Reports Full-Year 2021 Financial Results and Recent Corporate Highlights

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, each as amended, that ...